Radioligand therapy (RLT) used to treat cardiac metastasis of pancreatic neuroendocrine tumor

Radioligand therapy (RLT) used to treat cardiac metastasis of pancreatic neuroendocrine tumor

Key Clinical Message Radioligand Therapy (RLT) in the form of [177Lu] Lu‐DOTA‐TATE (Lutathera®) is a promising treatment for pancreatic neuroendocrine tumors (pNETs) with cardiac metastasis. We present a patient treated with [177Lu] Lu‐DOTA‐TATE that showed shrinkage of metastasis after four treatme...

Full description

Bibliographic Details
Main Authors: Kieran J. Ved, Arjun Bhatt, Aidan M. Burke, Michael C. Larkins, Dishita Pandya, Constantin B. Marcu
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Clinical Case Reports
Subjects:
cardiac metastases
Lutathera
neuroendocrine neoplasms (NENs)
peptide receptor radiotherapy (PRRT)
somatostatin receptor
Online Access:https://doi.org/10.1002/ccr3.8622

Internet

https://doi.org/10.1002/ccr3.8622

Similar Items